Welcome to our dedicated page for SELECTIS HEALTH news (Ticker: GBCS), a resource for investors and traders seeking the latest updates and insights on SELECTIS HEALTH stock.
Selectis Health Inc. operates as a public healthcare company focused on healthcare facilities that provide living services, speech, occupational and physical therapies, social services, rehabilitation and related healthcare services. The company has described its facility footprint across Arkansas, Georgia, Ohio and Oklahoma, with an emphasis on care settings serving aging populations.
Recurring developments for GBCS include skilled nursing facility portfolio changes, completed asset sales, material agreements, capital-structure updates, shareholder voting matters and operating and financial results. Company announcements also cover governance changes, including board and executive appointments, as well as healthcare regulatory disclosure topics tied to its facility operations.
Black Pearl Equities completed its tender offer, via a wholly owned subsidiary, to acquire all outstanding common shares of Selectis Health (OTCQB:GBCS) for $5.75 per share in cash. The offer expired at 5:00 p.m. New York City time on August 31, 2026.
As of expiration, 2,789,027 shares, or approximately 90.93% of Selectis’ outstanding common stock, were validly tendered and not withdrawn, and have been accepted for payment. Black Pearl expects to complete the acquisition through a merger under Utah law, with remaining shares converted into the right to receive $5.75 in cash per share, after which Selectis will become an indirect wholly owned subsidiary of Black Pearl. Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions is the depositary.
Selectis Health (OTCQB:GBCS) stockholders are being targeted in an extended tender offer by New York-based Black Pearl Equities to acquire all outstanding common shares for $5.75 per share in cash. The offer, originally set to expire on August 27, 2026 at 5:00 p.m. New York City time, has been extended to August 31, 2026 at the same time, unless further extended, while conditions to closing continue to be addressed.
Broadridge Corporate Issuer Solutions, the depositary, advised that 2,786,482 shares had been validly tendered and not withdrawn as of August 27, 2026. Laurel Hill Advisory Group is acting as information agent, providing tender documents and support to Selectis stockholders.
Selectis Health (OTCQB: GBCS) announced that Black Pearl Equities has extended the expiration of its previously disclosed cash tender offer to purchase all outstanding Selectis common shares at $5.75 per share. The offer, originally set to end at 5:00 p.m. on August 24, 2026, will now expire at 5:00 p.m., New York City time, on August 27, 2026, unless further extended, while conditions to consummate the offer continue to be addressed.
According to Black Pearl, 2,773,036 shares had been validly tendered and not withdrawn as of August 24, 2026. Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions is acting as depositary for the tender offer.
Black Pearl Equities extended the expiration of its cash tender offer to purchase all outstanding shares of Selectis Health (OTCQB: GBCS) at $5.75 per share. The offer, previously set to end on August 17, 2026, will now expire at 5:00 p.m. New York City time on August 24, 2026, unless further extended, while conditions to closing continue to be addressed.
According to Black Pearl, 2,769,282 shares had been validly tendered and not withdrawn as of August 17, 2026. Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions is serving as depositary for the tender offer.
Black Pearl Equities has extended its tender offer to purchase all outstanding common shares of Selectis Health (OTCQB: GBCS) for $5.75 per share in cash. The offer, previously set to expire on August 10, 2026, will now expire at 5:00 p.m. New York City time on August 17, 2026, unless further extended. All other terms and conditions are unchanged.
According to Black Pearl, closing remains subject to a minimum tender of 70% of Selectis’ outstanding shares, required regulatory approvals and customary closing conditions. The offer is not subject to financing contingencies. Broadridge, the depositary, reported that 2,807,869 shares had been validly tendered and not withdrawn as of August 10, 2026.
Selectis Health (OTCQB: GBCS) has become the target of a cash tender offer launched by New York-based investment group Black Pearl Equities to acquire all outstanding Selectis common shares at $5.75 per share, pursuant to a June 22, 2026 Agreement and Plan of Merger.
The tender offer expires at 5:00 p.m. New York City time on August 10, 2026, unless extended, and is conditioned on at least 70% of outstanding shares being validly tendered, receipt of required regulatory approvals, and other customary closing conditions. The transaction is not subject to financing contingencies.
Following successful completion of the tender offer, Black Pearl plans a short-form merger of a wholly owned subsidiary into Selectis under Utah law, cashing out remaining shares at $5.75 per share (with limited exceptions). Selectis’ board has unanimously recommended that stockholders accept the tender offer. Laurel Hill Advisory Group is the information agent, and Broadridge Corporate Issuer Solutions is the depositary.
Black Pearl Equities has commenced a cash tender offer to acquire all outstanding shares of Selectis Health (OTCQB: GBCS) at $5.75 per share, under a June 22, 2026 Agreement and Plan of Merger between Black Pearl affiliates and Selectis.
The offer expires at 5:00 p.m. New York City time on August 10, 2026, unless extended. Closing conditions include at least 70% of outstanding shares being validly tendered, required regulatory approvals, and other customary conditions, with no financing contingency disclosed.
After the tender, Black Pearl plans a short-form merger under Utah law, cashing out remaining shares at $5.75 per share, without interest and subject to tax withholding. Selectis’ board unanimously recommends shareholders accept the offer. Laurel Hill Advisory Group is information agent and Broadridge Corporate Issuer Solutions is depositary.
Selectis Health (OTCQB:GBCS) agreed to be acquired by affiliates of Black Pearl Equities for $5.75 per share in cash via a tender offer.
Black Pearl will launch the offer within ten business days. Closing is targeted for Q3 2026, requiring at least 70% of shares tendered, regulatory approvals, and other customary conditions. The board unanimously approved the deal, which has no financing contingency and will be followed by a short-form merger under Utah law.
Black Pearl Equities has commenced a cash tender offer to buy up to 100% of Selectis Health (OTCQB: GBCS) at $5.05 per share, representing a 45% premium to the trading price as of March 11, 2026. The offer expires at 5:00 p.m. ET on May 11, 2026, unless extended.
The transaction is subject to conditions including a minimum 51% tender, absence of a material adverse change, and customary closing conditions. The Selectis Health board has not yet responded. Shareholders should review the Schedule TO and Offer to Purchase and may contact D.F. King & Co. at (800) 769-4414 for assistance.
Selectis Health (OTC: GBCS) completed the sale of two Georgia skilled nursing properties—Providence of Sparta Health & Rehab and Warrenton Health & Rehabilitation—for an aggregate purchase price of $13,175,000, effective January 15, 2026. After payment of senior mortgages, transaction costs and a $1.3 million holdback, the company derived approximately $5.4 million in net proceeds.
From those proceeds Selectis paid $475,000 to settle title issues, $1.8 million to redeem senior secured notes, $700,000 to reduce capital lines of credit used for accrued bed taxes, and $700,000 to retire a mortgage on another facility; the remaining balance will be used for general working capital. Selectis will continue to own and operate several remaining facilities, including two in Georgia.